These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17256451

  • 1. Impaired clearance of phenacetin in hepatic cirrhosis and fibrosis.
    Qu ZQ, Li XD, Liu HL, He P, Zhang X, Wu MC.
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):55-62. PubMed ID: 17256451
    [Abstract] [Full Text] [Related]

  • 2. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W, Qu ZQ, Li XD, He P, Ding N, Zhang SL, Wu MC.
    J Clin Pharm Ther; 2008 Oct; 33(5):489-93. PubMed ID: 18834363
    [Abstract] [Full Text] [Related]

  • 3. Activity of sulfotransferase 1A1 is dramatically upregulated in patients with hepatocellular carcinoma secondary to chronic hepatitis B virus infection.
    Wang XR, Qu ZQ, Li XD, Liu HL, He P, Fang BX, Xiao J, Huang W, Wu MC.
    Cancer Sci; 2010 Feb; 101(2):412-5. PubMed ID: 19906068
    [Abstract] [Full Text] [Related]

  • 4. Assessment and monitoring of liver function by ¹³C-aminopyrine breath test after selective transarterial chemoembolisation of hepatocellular carcinoma.
    Schütte K, Seidensticker R, Milbradt O, Bornschein J, Kandulski A, Pech M, Kropf S, Ricke J, Malfertheiner P.
    Z Gastroenterol; 2015 Jan; 53(1):21-7. PubMed ID: 25594703
    [Abstract] [Full Text] [Related]

  • 5. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ, Kim B, Lee JD, Kang DR, Kim JK, Lee JH, Shin SJ, Lee KM, Yoo BM, Lee KJ, Kim SS, Cheong JY, Cho SW.
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B: liver fibrosis and hepatocellular carcinoma.
    Lok AS.
    Gastroenterol Clin Biol; 2009 Mar; 33(10-11):911-5. PubMed ID: 19577871
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 8. Evaluating human liver reserve function by measuring serum concentrations of phenacetin and its metabolites.
    Xiong WJ, Jin H, Li SJ, Jin JC, Ji BN, Yu C.
    J Dig Dis; 2010 Dec 02; 11(6):358-63. PubMed ID: 21091898
    [Abstract] [Full Text] [Related]

  • 9. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis.
    Kim BS, Seo YS, Kim YS, Lee CH, Lee HA, Um SH, Yoo JJ, Kim SG, Suh SJ, Jung YK, Ahn SH, Han KH, Yim HJ, Kim SU, Korean Transient Elastography Study Group.
    J Gastroenterol Hepatol; 2018 Feb 02; 33(2):503-510. PubMed ID: 28666070
    [Abstract] [Full Text] [Related]

  • 10. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G, Yao-jun Z, Min-shan C, Mei-xian C, Jun-ting H, Li X, Lau WY.
    Liver Int; 2014 Apr 02; 34(4):612-20. PubMed ID: 24028297
    [Abstract] [Full Text] [Related]

  • 11. Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2.
    Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M.
    Dig Dis; 2017 Apr 02; 35(6):589-597. PubMed ID: 29040992
    [Abstract] [Full Text] [Related]

  • 12. Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
    Jeng JE, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF.
    Asian Pac J Cancer Prev; 2014 Apr 02; 15(2):637-42. PubMed ID: 24568470
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, Chung JW, Park JH, Kim CY.
    J Clin Oncol; 2002 Nov 15; 20(22):4459-65. PubMed ID: 12431969
    [Abstract] [Full Text] [Related]

  • 14. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE, Wu HF, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF.
    Asian Pac J Cancer Prev; 2014 Nov 15; 15(23):10209-15. PubMed ID: 25556449
    [Abstract] [Full Text] [Related]

  • 15. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.
    Huang YS, Chiang JH, Wu JC, Chang FY, Lee SD.
    Am J Gastroenterol; 2002 May 15; 97(5):1223-7. PubMed ID: 12014732
    [Abstract] [Full Text] [Related]

  • 16. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK, HEPNET. Greece Cohort Study Group.
    Gut; 2011 Aug 15; 60(8):1109-16. PubMed ID: 21270118
    [Abstract] [Full Text] [Related]

  • 17. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P.
    J Surg Res; 2009 Dec 15; 157(2):199-207. PubMed ID: 19540521
    [Abstract] [Full Text] [Related]

  • 18. Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients.
    Gao H, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Qin R, Yan L, Xiao G.
    Oncotarget; 2017 Jan 17; 8(3):4289-4300. PubMed ID: 28008144
    [Abstract] [Full Text] [Related]

  • 19. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF, Hsu CY, Huang HC, Huang YH, Lin HC, Lee RC, Chiang JH, Lee FY, Huo TI, Lee SD.
    J Clin Gastroenterol; 2011 Jul 17; 45(6):556-62. PubMed ID: 21666547
    [Abstract] [Full Text] [Related]

  • 20. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
    Caturelli E, Siena DA, Fusilli S, Villani MR, Schiavone G, Nardella M, Balzano S, Florio F.
    Radiology; 2000 Apr 17; 215(1):123-8. PubMed ID: 10751477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.